Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-10-18 Purchase |
2023-10-31 07:08 am |
Ayala Pharmaceuticals Inc. | ADXS | Israel Biotech Fund I L.P. Israel Biotech Fund II L.P. Israel Biotech Fund GP Partners L.P. Israel Biotech Fund GP Partners II L.P. I.B.F. Management Ltd. 10% Owner |
1,317,716 | $0 | $0 | 1,094,091 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-03-01 Exercise |
2024-03-06 07:13 am |
2023-11-17 N/A |
Ayala Pharmaceuticals Inc. | ADXS | Israel Biotech Fund I L.P. Israel Biotech Fund II L.P. Israel Biotech Fund GP Partners L.P. Israel Biotech Fund GP Partners II L.P. I.B.F. Management Ltd. Director 10% Owner |
15,000,000 | $0 | 51,900,000 (Indirect) |
View |
| 2024-02-07 Tax Withholding |
2024-02-12 2:16 pm |
N/A N/A |
Ayala Pharmaceuticals Inc. | ADXS | Israel Biotech Fund I L.P. Israel Biotech Fund II L.P. Israel Biotech Fund GP Partners L.P. Israel Biotech Fund GP Partners II L.P. I.B.F. Management Ltd. Director 10% Owner |
5,294,486 | $1.2465 | 105,571,313 (Indirect) |
View |
| 2024-02-07 Exercise |
2024-02-12 2:16 pm |
N/A N/A |
Ayala Pharmaceuticals Inc. | ADXS | Israel Biotech Fund I L.P. Israel Biotech Fund II L.P. Israel Biotech Fund GP Partners L.P. Israel Biotech Fund GP Partners II L.P. I.B.F. Management Ltd. Director 10% Owner |
27,847,159 | $0.4 | 105,571,313 (Indirect) |
View |
| 2024-02-07 Exercise |
2024-02-12 2:16 pm |
2023-11-17 2028-11-17 |
Ayala Pharmaceuticals Inc. | ADXS | Israel Biotech Fund I L.P. Israel Biotech Fund II L.P. Israel Biotech Fund GP Partners L.P. Israel Biotech Fund GP Partners II L.P. I.B.F. Management Ltd. Director 10% Owner |
27,847,159 | $0 | 105,571,313 (Indirect) |
View |
Ownership(A) |
2023-09-29 06:10 am |
N/A N/A |
Ayala Pharmaceuticals Inc. | ADXS | Israel Biotech Fund I L.P. Israel Biotech Fund GP Partners L.P. I.B.F. Management Ltd. 10% Owner |
0 | $0 | 621,253 (Indirect) |
View |